Johnson & Johnson (JNJ.N) on Tuesday reported quarterly results that beat analysts’ estimates on strong demand for cancer drug Darzalex and its COVID-19 vaccine, even…
View More J&J’s Cancer Drug Sales Help Weather Hit From Stronger DollarJohnson & Johnson (JNJ.N) on Tuesday reported quarterly results that beat analysts’ estimates on strong demand for cancer drug Darzalex and its COVID-19 vaccine, even…
View More J&J’s Cancer Drug Sales Help Weather Hit From Stronger Dollar